Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

bluebird bio Inc (NASDAQ:BLUE)

137.47
Delayed Data
As of Aug 28
 +4.11 / +3.08%
Today’s Change
29.73
Today|||52-Week Range
197.35
+49.88%
Year-to-Date

Today’s Trading

Previous close133.36
Today’s open133.26
Day’s range131.64 - 138.67
Volume584,778
Average volume (3 months)929,187
Market cap$5.0B
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+9.41%
Earnings growth (this year)-132.40%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+25.97%
P/E ratioNM
Price/Sales95.78
Price/Book9.05

Competitors

 Today’s
change
Today’s
% change
XONIntrexon Corp+1.93+4.31%
CTLTCatalent Inc+0.20+0.63%
JUNOJuno Therapeutics In...+0.65+1.74%
NVAXNovavax Inc0.000.00%
Data as of 4:04pm ET, 08/28/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)-$0.95
Annual revenue (last year)$25.4M
Annual profit (last year)-$48.7M
Net profit margin-191.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nick Leschly
Chief Operating Officer
Jeffrey T. Walsh
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers